Coherus Accumulated Other Comprehensive Income from 2010 to 2025
| CHRS Stock | USD 1.39 0.03 2.11% |
Accumulated Other Comprehensive Income | First Reported 2013-12-31 | Previous Quarter -272 K | Current Value -275 K | Quarterly Volatility 201.2 K |
Check Coherus BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coherus BioSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 M, Interest Expense of 49 M or Selling General Administrative of 231.9 M, as well as many indicators such as Price To Sales Ratio of 1.33, Dividend Yield of 0.0 or Days Sales Outstanding of 349. Coherus financial statements analysis is a perfect complement when working with Coherus BioSciences Valuation or Volatility modules.
Coherus | Accumulated Other Comprehensive Income |
Latest Coherus BioSciences' Accumulated Other Comprehensive Income Growth Pattern
Below is the plot of the Accumulated Other Comprehensive Income of Coherus BioSciences over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Coherus BioSciences' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coherus BioSciences' overall financial position and show how it may be relating to other accounts over time.
| Accumulated Other Comprehensive Income | 10 Years Trend |
|
Accumulated Other Comprehensive Income |
| Timeline |
Coherus Accumulated Other Comprehensive Income Regression Statistics
| Arithmetic Mean | (379,416) | |
| Geometric Mean | 346,620 | |
| Coefficient Of Variation | (46.53) | |
| Mean Deviation | 151,563 | |
| Median | (282,000) | |
| Standard Deviation | 176,556 | |
| Sample Variance | 31.2B | |
| Range | 524K | |
| R-Value | 0.17 | |
| Mean Square Error | 32.4B | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | 6,462 | |
| Total Sum of Squares | 467.6B |
Coherus Accumulated Other Comprehensive Income History
About Coherus BioSciences Financial Statements
Coherus BioSciences shareholders use historical fundamental indicators, such as Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although Coherus BioSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Coherus BioSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Coherus BioSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -285.2 K | -299.5 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.